Next Article in Journal
Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy
Previous Article in Journal
Insights into HIV-1 Reverse Transcriptase (RT) Inhibition and Drug Resistance from Thirty Years of Structural Studies
Previous Article in Special Issue
DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks)
 
 
Article

Article Versions Notes

Viruses 2022, 14(5), 1028; https://doi.org/10.3390/v14051028
Action Date Notes Link
article pdf uploaded. 11 May 2022 15:14 CEST Version of Record https://www.mdpi.com/1999-4915/14/5/1028/pdf-vor
article supplementary file uploaded. 11 May 2022 15:14 CEST - https://www.mdpi.com/1999-4915/14/5/1028#supplementary
article xml file uploaded 12 May 2022 03:40 CEST Original file -
article xml uploaded. 12 May 2022 03:40 CEST Update https://www.mdpi.com/1999-4915/14/5/1028/xml
article pdf uploaded. 12 May 2022 03:40 CEST Updated version of record https://www.mdpi.com/1999-4915/14/5/1028/pdf
article html file updated 12 May 2022 03:42 CEST Original file -
article html file updated 2 August 2022 23:23 CEST Update https://www.mdpi.com/1999-4915/14/5/1028/html
Back to TopTop